Acute respiratory distress syndrome: the Berlin Definition.

…, GD Rubenfeld, B Taylor Thompson… - JAMA: Journal of …, 2012 - search.ebscohost.com
The article focuses on the issues regarding the reliability and validity of the acute respiratory
distress syndrome (ARDS) definition which was discussed in the 1994 American-European …

[HTML][HTML] Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016

…, KA Shukri, SQ Simpson, M Singer, BT Thompson… - Intensive care …, 2017 - Springer
Objective To provide an update to “Surviving Sepsis Campaign Guidelines for Management
of Sepsis and Septic Shock: 2012”. Design A consensus committee of 55 international …

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

…, G Ramsay, J Sevransky, BT Thompson… - Critical care …, 2008 - journals.lww.com
Objective: To provide an update to the original Surviving Sepsis Campaign clinical management
guidelines,“Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis …

Incidence of adverse drug events and potential adverse drug events: implications for prevention

…, MD Clapp, T Gallivan, J Ives, K Porter, BT Thompson… - Jama, 1995 - jamanetwork.com
Objectives. —To assess incidence and preventability of adverse drug events (ADEs) and
potential ADEs. To analyze preventable events to develop prevention strategies. Design. —…

Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries

…, DF McAuley, M Ranieri, G Rubenfeld, BT Thompson… - Jama, 2016 - jamanetwork.com
Importance Limited information exists about the epidemiology, recognition, management,
and outcomes of patients with the acute respiratory distress syndrome (ARDS). Objectives To …

Systems analysis of adverse drug events

…, BF Shea, SD Small, BJ Sweitzer, BT Thompson… - Jama, 1995 - jamanetwork.com
Objective. —To identify and evaluate the systems failures that underlie errors causing
adverse drug events (ADEs) and potential ADEs. Design. —Systems analysis of events from a …

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled …

…, RL Greenman, HD Reines, MP Shelly, BW Thompson… - Jama, 1994 - jamanetwork.com
Objective. —To further define the safety and efficacy of recombinant human interleukin 1
receptor antagonist (rhIL-1ra) in the treatment of sepsis syndrome. Study Design. —Randomized…

Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy

…, A Rosano, E Storti, BT Thompson… - JAMA internal …, 2020 - jamanetwork.com
Importance Many patients with coronavirus disease 2019 (COVID-19) are critically ill and
require care in the intensive care unit (ICU). Objective To evaluate the independent risk factors …

[HTML][HTML] Drotrecogin alfa (activated) in adults with septic shock

VM Ranieri, BT Thompson, PS Barie… - … England Journal of …, 2012 - Mass Medical Soc
Background There have been conflicting reports on the efficacy of recombinant human
activated protein C, or drotrecogin alfa (activated) (DrotAA), for the treatment of patients with …

[HTML][HTML] The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material

…, JL Vincent, GD Rubenfeld, BT Thompson… - Intensive care …, 2012 - Springer
Purpose Our objective was to revise the definition of acute respiratory distress syndrome (ARDS)
using a conceptual model incorporating reliability and validity, and a novel iterative …